TreeWAS – Variant ID: rs251253

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.701	0.299
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.707	0.293
T42.4 Benzodiazepines	0.000	0.711	0.289
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.711	0.289
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.712	0.288
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.725	0.275
T43.2 Other and unspecified antidepressants	0.000	0.729	0.271
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.731	0.269
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.732	0.268
T36 Poisoning by systemic antibiotics	0.000	0.735	0.265
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.739	0.261
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.748	0.252
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.749	0.251
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.754	0.246
T42.0 Hydantoin derivatives	0.000	0.761	0.239
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.762	0.238
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.764	0.236
T43.6 Psychostimulants with abuse potential	0.000	0.770	0.230
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.772	0.228
T36.4 Tetracyclines	0.000	0.778	0.222
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.780	0.220
T46.1 Calcium-channel blockers	0.000	0.780	0.220
T36.3 Macrolides	0.000	0.782	0.218
T43.9 Psychotropic drug, unspecified	0.000	0.786	0.214
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.786	0.214
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.786	0.214
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.786	0.214
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.787	0.213
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.789	0.211
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.789	0.211
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.790	0.210
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.790	0.210
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.791	0.209
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.792	0.207
T42.2 Succinimides and oxazolidinediones	0.000	0.792	0.207
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.793	0.207
T46.7 Peripheral vasodilators	0.000	0.793	0.207
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.798	0.202
T47.4 Other laxatives	0.000	0.799	0.201
T45.0 Antiallergic and antiemetic drugs	0.000	0.800	0.200
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.801	0.199
T47.6 Antidiarrhoeal drugs	0.000	0.801	0.199
T36.0 Penicillins	0.000	0.802	0.198
T45.2 Vitamins, not elsewhere classified	0.000	0.802	0.198
T47.2 Stimulant laxatives	0.000	0.806	0.194
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.807	0.192
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.808	0.192
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.808	0.192
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.808	0.192
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.808	0.192
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.808	0.192
T44.0 Anticholinesterase agents	0.000	0.808	0.192
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.808	0.192
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.808	0.191
T36.9 Systemic antibiotic, unspecified	0.000	0.810	0.190
T36.8 Other systemic antibiotics	0.000	0.810	0.190
T36.7 Antifungal antibiotics, systemically used	0.000	0.810	0.190
T36.6 Rifamycins	0.000	0.810	0.190
T36.5 Aminoglycosides	0.000	0.810	0.190
T36.2 Chloramphenicol group	0.000	0.810	0.190
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.810	0.190
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.813	0.187
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.813	0.187
T47.7 Emetics	0.000	0.813	0.187
T47.5 Digestants	0.000	0.813	0.187
T47.3 Saline and osmotic laxatives	0.000	0.813	0.187
T39.0 Salicylates	0.000	0.815	0.185
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.815	0.185
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.817	0.183
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.817	0.183
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.821	0.179
T42.3 Barbiturates	0.000	0.821	0.179
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.822	0.178
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.823	0.176
T45.8 Other primarily systemic and haematological agents	0.000	0.823	0.176
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.823	0.176
T45.6 Fibrinolysis-affecting drugs	0.000	0.823	0.176
T45.4 Iron and its compounds	0.000	0.823	0.176
T45.3 Enzymes, not elsewhere classified	0.000	0.823	0.176
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.826	0.174
T47.0 Histamine H(2)-receptor antagonists	0.000	0.835	0.165
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.838	0.162
T45.5 Anticoagulants	0.000	0.838	0.161
T50.7 Analeptics and opioid receptor antagonists	0.000	0.842	0.158
T50.5 Appetite depressants	0.000	0.842	0.158
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.842	0.158
T50.0 Mineralocorticoids and their antagonists	0.000	0.842	0.158
T50.4 Drugs affecting uric acid metabolism	0.000	0.842	0.157
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.845	0.155
T41.5 Therapeutic gases	0.000	0.846	0.154
T41.4 Anaesthetic, unspecified	0.000	0.846	0.154
T41.3 Local anaesthetics	0.000	0.846	0.154
T41.2 Other and unspecified general anaesthetics	0.000	0.846	0.154
T41.1 Intravenous anaesthetics	0.000	0.846	0.154
T41.0 Inhaled anaesthetics	0.000	0.846	0.154
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.846	0.154
T49.9 Topical agent, unspecified	0.000	0.846	0.153
T49.8 Other topical agents	0.000	0.846	0.153
T49.7 Dental drugs, topically applied	0.000	0.846	0.153
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.846	0.153
T49.5 Ophthalmological drugs and preparations	0.000	0.846	0.153
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.846	0.153
T49.3 Emollients, demulcents and protectants	0.000	0.846	0.153
T49.2 Local astringents and local detergents	0.000	0.846	0.153
T49.1 Antipruritics	0.000	0.846	0.153
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.847	0.153
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.848	0.151
T37.5 Antiviral drugs	0.000	0.848	0.151
T37.4 Anthelminthics	0.000	0.848	0.151
T37.3 Other antiprotozoal drugs	0.000	0.848	0.151
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.848	0.151
T37.1 Antimycobacterial drugs	0.000	0.848	0.151
T37.0 Sulphonamides	0.000	0.848	0.151
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.850	0.150
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.852	0.148
T50.1 Loop [high-ceiling] diuretics	0.000	0.853	0.147
T50.8 Diagnostic agents	0.000	0.854	0.145
T39.4 Antirheumatics, not elsewhere classified	0.000	0.857	0.143
T39.2 Pyrazolone derivatives	0.000	0.857	0.143
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.858	0.142
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.862	0.138
T48.4 Expectorants	0.000	0.862	0.138
T48.3 Antitussives	0.000	0.862	0.138
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.862	0.138
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.862	0.138
T48.0 Oxytocic drugs	0.000	0.862	0.138
T48.5 Anti-common-cold drugs	0.000	0.863	0.136
T42.1 Iminostilbenes	0.000	0.864	0.136
T38.9 Other and unspecified hormone antagonists	0.000	0.867	0.133
T38.7 Androgens and anabolic congeners	0.000	0.867	0.133
T38.5 Other oestrogens and progestogens	0.000	0.867	0.133
T38.4 Oral contraceptives	0.000	0.867	0.133
T38.2 Antithyroid drugs	0.000	0.867	0.133
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.869	0.131
T38.0 Glucocorticoids and synthetic analogues	0.000	0.871	0.129
T38.1 Thyroid hormones and substitutes	0.000	0.871	0.129
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.875	0.125
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.878	0.121
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.882	0.117
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.895	0.105
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.911	0.088
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.939	0.061
T40.3 Methadone	0.000	0.954	0.046
T51.0 Ethanol	0.000	0.954	0.046
T40.1 Heroin	0.000	0.955	0.045
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.956	0.044
T40.8 Lysergide [LSD]	0.000	0.956	0.044
T40.7 Cannabis (derivatives)	0.000	0.956	0.044
T40.0 Opium	0.000	0.956	0.044
T40.5 Cocaine	0.000	0.959	0.041
T39.1 4-Aminophenol derivatives	0.000	0.968	0.032
D12.4 Descending colon	0.000	0.969	0.031
T40.6 Other and unspecified narcotics	0.001	0.973	0.027
T51 Toxic effect of alcohol	0.000	0.974	0.026
T40.4 Other synthetic narcotics	0.000	0.975	0.024
Q63.0 Accessory kidney	0.023	0.977	0.000
T51.9 Alcohol, unspecified	0.000	0.979	0.021
Q63 Other congenital malformations of kidney	0.019	0.981	0.000
T51.8 Other alcohols	0.000	0.981	0.019
T51.3 Fusel oil	0.000	0.981	0.019
T51.2 2-Propanol	0.000	0.981	0.019
T51.1 Methanol	0.000	0.981	0.019
T40.2 Other opioids	0.000	0.982	0.018
S61.9 Open wound of wrist and hand, part unspecified	0.018	0.982	0.000
F10.0 Acute intoxication	0.000	0.983	0.017
Q63.1 Lobulated, fused and horseshoe kidney	0.016	0.984	0.000
Q63.8 Other specified congenital malformations of kidney	0.015	0.984	0.000
Q63.3 Hyperplastic and giant kidney	0.014	0.986	0.000
Q63.9 Congenital malformation of kidney, unspecified	0.014	0.986	0.000
Q63.2 Ectopic kidney	0.014	0.986	0.000
Q60-Q64 Congenital malformations of the urinary system	0.014	0.986	0.000
I31.3 Pericardial effusion (noninflammatory)	0.013	0.987	0.000
Q61 Cystic kidney disease	0.013	0.987	0.000
H54.4 Blindness, one eye	0.000	0.988	0.012
Q61.2 Polycystic kidney, adult type	0.012	0.988	0.000
Q61.3 Polycystic kidney, unspecified	0.011	0.988	0.000
Q61.9 Cystic kidney disease, unspecified	0.011	0.989	0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.011	0.989	0.000
Q61.4 Renal dysplasia	0.011	0.989	0.000
Q61.8 Other cystic kidney diseases	0.009	0.990	0.000
Q61.1 Polycystic kidney, infantile type	0.009	0.990	0.000
Q64 Other congenital malformations of urinary system	0.009	0.991	0.000
K66.0 Peritoneal adhesions	0.000	0.991	0.009
Z11.5 Special screening examination for other viral diseases	0.000	0.991	0.009
Q62.5 Duplication of ureter	0.009	0.991	0.000
Q62.2 Congenital megaloureter	0.008	0.991	0.000
Q62.8 Other congenital malformations of ureter	0.008	0.992	0.000
K22.8 Other specified diseases of oesophagus	0.008	0.992	0.000
M16.0 Primary coxarthrosis, bilateral	0.008	0.992	0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.000	0.992	0.008
Q62.7 Congenital vesico-uretero-renal reflux	0.008	0.992	0.000
Q62.6 Malposition of ureter	0.008	0.992	0.000
Q62.4 Agenesis of ureter	0.008	0.992	0.000
Q62.3 Other obstructive defects of renal pelvis and ureter	0.008	0.992	0.000
Q62.0 Congenital hydronephrosis	0.008	0.992	0.000
Q60 Renal agenesis and other reduction defects of kidney	0.008	0.992	0.000
Q62.1 Atresia and stenosis of ureter	0.008	0.992	0.000
Z11.4 Special screening examination for human immunodeficiency virus [HIV]	0.000	0.992	0.008
Q64.7 Other congenital malformations of bladder and urethra	0.007	0.992	0.000
Q61.5 Medullary cystic kidney	0.007	0.993	0.000
Q64.9 Congenital malformation of urinary system, unspecified	0.007	0.993	0.000
Q64.8 Other specified congenital malformations of urinary system	0.007	0.993	0.000
Q64.6 Congenital diverticulum of bladder	0.007	0.993	0.000
Q64.5 Congenital absence of bladder and urethra	0.007	0.993	0.000
Q64.2 Congenital posterior urethral valves	0.007	0.993	0.000
Q64.1 Exstrophy of urinary bladder	0.007	0.993	0.000
Q64.0 Epispadias	0.007	0.993	0.000
Q64.4 Malformation of urachus	0.007	0.993	0.000
S46.0 Injury of tendon of the rotator cuff of shoulder	0.000	0.993	0.007
Z11 Special screening examination for infectious and parasitic diseases	0.000	0.993	0.007
Q60.3 Renal hypoplasia, unilateral	0.006	0.993	0.000
T63 Toxic effect of contact with venomous animals	0.000	0.993	0.007
T62 Toxic effect of other noxious substances eaten as food	0.000	0.993	0.006
T60 Toxic effect of pesticides	0.000	0.994	0.006
T57 Toxic effect of other inorganic substances	0.000	0.994	0.006
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.000	0.994	0.006
T52 Toxic effect of organic solvents	0.000	0.994	0.006
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.000	0.994	0.006
T55 Toxic effect of soaps and detergents	0.000	0.994	0.006
Q60.6 Potter's syndrome	0.006	0.994	0.000
Q60.5 Renal hypoplasia, unspecified	0.006	0.994	0.000
Q60.4 Renal hypoplasia, bilateral	0.006	0.994	0.000
Q60.1 Renal agenesis, bilateral	0.006	0.994	0.000
H54 Blindness and low vision	0.000	0.994	0.006
Z11.9 Special screening examination for infectious and parasitic diseases, unspecified	0.000	0.994	0.006
T59 Toxic effect of other gases, fumes and vapours	0.000	0.994	0.006
T54 Toxic effect of corrosive substances	0.000	0.994	0.006
H49.2 Sixth [abducent] nerve palsy	0.006	0.994	0.000
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.006	0.994	0.000
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.994	0.006
Q61.0 Congenital single renal cyst	0.006	0.994	0.000
T56 Toxic effect of metals	0.000	0.994	0.006
H54.7 Unspecified visual loss	0.000	0.994	0.006
T58 Toxic effect of carbon monoxide	0.000	0.994	0.006
T63.4 Venom of other arthropods	0.000	0.994	0.006
T61 Toxic effect of noxious substances eaten as seafood	0.000	0.994	0.006
Z50.5 Speech therapy	0.000	0.994	0.006
Q60.2 Renal agenesis, unspecified	0.005	0.994	0.000
Z11.2 Special screening examination for other bacterial diseases	0.000	0.994	0.006
H54.2 Low vision, both eyes	0.000	0.994	0.006
T65 Toxic effect of other and unspecified substances	0.000	0.994	0.005
K66 Other disorders of peritoneum	0.000	0.994	0.005
H49 Paralytic strabismus	0.005	0.995	0.000
I31 Other diseases of pericardium	0.005	0.995	0.000
T62.9 Noxious substance eaten as food, unspecified	0.000	0.995	0.005
J93.9 Pneumothorax, unspecified	0.000	0.995	0.005
Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission	0.000	0.995	0.005
K59.3 Megacolon, not elsewhere classified	0.000	0.995	0.005
H49.1 Fourth [trochlear] nerve palsy	0.005	0.995	0.000
H54.6 Unqualified visual loss, one eye	0.000	0.995	0.005
T63.8 Toxic effect of contact with other venomous animals	0.000	0.995	0.005
T63.6 Toxic effect of contact with other marine animals	0.000	0.995	0.005
T63.5 Toxic effect of contact with fish	0.000	0.995	0.005
T63.3 Venom of spider	0.000	0.995	0.005
T63.2 Venom of scorpion	0.000	0.995	0.005
T63.1 Venom of other reptiles	0.000	0.995	0.005
T63.0 Snake venom	0.000	0.995	0.005
H49.0 Third [oculomotor] nerve palsy	0.005	0.995	0.000
T62.8 Other specified noxious substances eaten as food	0.000	0.995	0.005
T62.2 Other ingested (parts of) plant(s)	0.000	0.995	0.005
T62.1 Ingested berries	0.000	0.995	0.005
T62.0 Ingested mushrooms	0.000	0.995	0.005
Z11.1 Special screening examination for respiratory tuberculosis	0.000	0.995	0.005
K66.8 Other specified disorders of peritoneum	0.000	0.995	0.005
H52.0 Hypermetropia	0.005	0.995	0.000
T59.8 Other specified gases, fumes and vapours	0.000	0.995	0.005
I30.9 Acute pericarditis, unspecified	0.005	0.995	0.000
H54.1 Blindness, one eye, low vision, other eye	0.000	0.995	0.005
T52.9 Organic solvent, unspecified	0.000	0.995	0.005
T52.8 Other organic solvents	0.000	0.995	0.005
T52.4 Ketones	0.000	0.995	0.005
T52.3 Glycols	0.000	0.995	0.005
T52.2 Homologues of benzene	0.000	0.995	0.005
T52.1 Benzene	0.000	0.995	0.005
T52.0 Petroleum products	0.000	0.995	0.005
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified	0.000	0.995	0.005
T53.7 Other halogen derivatives of aromatic hydrocarbons	0.000	0.995	0.005
T53.6 Other halogen derivatives of aliphatic hydrocarbons	0.000	0.995	0.005
T53.5 Chlorofluorocarbons	0.000	0.995	0.005
T53.4 Dichloromethane	0.000	0.995	0.005
T53.3 Tetrachloroethylene	0.000	0.995	0.005
T53.2 Trichloroethylene	0.000	0.995	0.005
T53.1 Chloroform	0.000	0.995	0.005
T53.0 Carbon tetrachloride	0.000	0.995	0.005
T57.9 Inorganic substance, unspecified	0.000	0.995	0.005
T57.8 Other specified inorganic substances	0.000	0.995	0.005
T57.3 Hydrogen cyanide	0.000	0.995	0.005
T57.2 Manganese and its compounds	0.000	0.995	0.005
T57.1 Phosphorus and its compounds	0.000	0.995	0.005
T57.0 Arsenic and its compounds	0.000	0.995	0.005
T60.9 Pesticide, unspecified	0.000	0.995	0.005
T60.8 Other pesticides	0.000	0.995	0.005
T60.4 Rodenticides	0.000	0.995	0.005
T60.3 Herbicides and fungicides	0.000	0.995	0.005
T60.2 Other insecticides	0.000	0.995	0.005
T60.1 Halogenated insecticides	0.000	0.995	0.005
T60.0 Organophosphate and carbamate insecticides	0.000	0.995	0.005
L84 Corns and callosities	0.005	0.995	0.000
H54.3 Unqualified visual loss, both eyes	0.000	0.995	0.005
Z11.6 Special screening examination for other protozoal diseases and helminthiases	0.000	0.995	0.005
T59.7 Carbon dioxide	0.000	0.995	0.004
T59.6 Hydrogen sulphide	0.000	0.995	0.004
T59.5 Fluorine gas and hydrogen fluoride	0.000	0.995	0.004
T59.4 Chlorine gas	0.000	0.995	0.004
T59.3 Lachrymogenic gas	0.000	0.995	0.004
T59.2 Formaldehyde	0.000	0.995	0.004
T59.1 Sulphur dioxide	0.000	0.995	0.004
T59.0 Nitrogen oxides	0.000	0.995	0.004
T54.3 Corrosive alkalis and alklali-like substances	0.000	0.995	0.004
T54.2 Corrosive acids and acid-like substances	0.000	0.995	0.004
T54.1 Other corrosive organic compounds	0.000	0.995	0.004
T54.0 Phenol and phenol homologues	0.000	0.995	0.004
M31.6 Other giant cell arteritis	0.000	0.995	0.005
T63.9 Toxic effect of contact with unspecified venomous animal	0.000	0.995	0.004
T56.9 Metal, unspecified	0.000	0.996	0.004
T56.7 Beryllium and its compounds	0.000	0.996	0.004
T56.6 Tin and its compounds	0.000	0.996	0.004
T56.5 Zinc and its compounds	0.000	0.996	0.004
T56.4 Copper and its compounds	0.000	0.996	0.004
T56.3 Cadmium and its compounds	0.000	0.996	0.004
T56.2 Chromium and its compounds	0.000	0.996	0.004
T56.1 Mercury and its compounds	0.000	0.996	0.004
T56.0 Lead and its compounds	0.000	0.996	0.004
T54.9 Corrosive substance, unspecified	0.000	0.996	0.004
T61.9 Toxic effect of unspecified seafood	0.000	0.996	0.004
T61.8 Toxic effect of other seafoods	0.000	0.996	0.004
T61.1 Scombroid fish poisoning	0.000	0.996	0.004
T61.0 Ciguatera fish poisoning	0.000	0.996	0.004
Z11.8 Special screening examination for other infectious and parasitic diseases	0.000	0.996	0.004
I31.0 Chronic adhesive pericarditis	0.004	0.996	0.000
H54.5 Low vision, one eye	0.000	0.996	0.004
H49.8 Other paralytic strabismus	0.004	0.996	0.000
H04.2 Epiphora	0.000	0.996	0.004
T59.9 Gases, fumes and vapours, unspecified	0.000	0.996	0.004
T65.8 Toxic effect of other specified substances	0.000	0.996	0.004
T65.6 Paints and dyes, not elsewhere classified	0.000	0.996	0.004
T65.5 Nitroglycerin and other nitric acids and esters	0.000	0.996	0.004
T65.4 Carbon disulphide	0.000	0.996	0.004
T65.3 Nitroderivatives and aminoderivatives of benzene and its homologues	0.000	0.996	0.004
T65.2 Tobacco and nicotine	0.000	0.996	0.004
T65.1 Strychnine and its salts	0.000	0.996	0.004
T65.0 Cyanides	0.000	0.996	0.004
H49.3 Total (external) ophthalmoplegia	0.004	0.996	0.000
I31.8 Other specified diseases of pericardium	0.004	0.996	0.000
I31.2 Haemopericardium, not elsewhere classified	0.004	0.996	0.000
H49.4 Progressive external ophthalmoplegia	0.004	0.996	0.000
Q60.0 Renal agenesis, unilateral	0.004	0.996	0.000
Z11.0 Special screening examination for intestinal infectious diseases	0.000	0.996	0.004
H52.2 Astigmatism	0.004	0.996	0.000
J01.9 Acute sinusitis, unspecified	0.000	0.996	0.004
T56.8 Other metals	0.000	0.996	0.004
T61.2 Other fish and shellfish poisoning	0.000	0.996	0.004
F52.2 Failure of genital response	0.004	0.996	0.000
I31.9 Disease of pericardium, unspecified	0.004	0.996	0.000
K66.1 Haemoperitoneum	0.000	0.996	0.004
H49.9 Paralytic strabismus, unspecified	0.004	0.996	0.000
I31.1 Chronic constrictive pericarditis	0.004	0.996	0.000
S60.9 Superficial injury of wrist and hand, unspecified	0.004	0.996	0.000
H52 Disorders of refraction and accommodation	0.004	0.996	0.000
K66.9 Disorder of peritoneum, unspecified	0.000	0.996	0.004
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.000	0.996	0.004
S61 Open wound of wrist and hand	0.004	0.996	0.000
T65.9 Toxic effect of unspecified substance	0.000	0.996	0.003
H52.4 Presbyopia	0.003	0.997	0.000
S46 Injury of muscle and tendon at shoulder and upper arm level	0.000	0.997	0.003
S46.2 Injury of muscle and tendon of other parts of biceps	0.000	0.997	0.003
K27 Peptic ulcer, site unspecified	0.000	0.997	0.003
S61.0 Open wound of finger(s) without damage to nail	0.003	0.997	0.000
M16.3 Other dysplastic coxarthrosis	0.003	0.997	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.000	0.997	0.003
L60.8 Other nail disorders	0.003	0.997	0.000
C21.1 Anal canal	0.003	0.997	0.000
H52.7 Disorder of refraction, unspecified	0.003	0.997	0.000
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.003	0.997	0.000
R49.0 Dysphonia	0.000	0.997	0.003
K76.6 Portal hypertension	0.000	0.997	0.003
H52.6 Other disorders of refraction	0.003	0.997	0.000
H52.5 Disorders of accommodation	0.003	0.997	0.000
R49.1 Aphonia	0.000	0.997	0.003
H54.0 Blindness, both eyes	0.000	0.997	0.003
K27.7 Chronic without haemorrhage or perforation	0.000	0.997	0.003
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.003	0.997	0.000
K27.3 Acute without haemorrhage or perforation	0.000	0.997	0.003
I24.8 Other forms of acute ischaemic heart disease	0.003	0.997	0.000
C16.0 Cardia	0.000	0.997	0.003
K27.4 Chronic or unspecified with haemorrhage	0.000	0.997	0.003
S46.7 Injury of multiple muscles and tendons at shoulder and upper arm level	0.000	0.997	0.003
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes	0.003	0.997	0.000
M16 Coxarthrosis [arthrosis of hip]	0.003	0.997	0.000
C21.0 Anus, unspecified	0.003	0.997	0.000
K27.6 Chronic or unspecified with both haemorrhage and perforation	0.000	0.997	0.003
K27.5 Chronic or unspecified with perforation	0.000	0.997	0.003
K27.2 Acute with both haemorrhage and perforation	0.000	0.997	0.003
K27.1 Acute with perforation	0.000	0.997	0.003
K27.0 Acute with haemorrhage	0.000	0.997	0.003
S46.1 Injury of muscle and tendon of long head of biceps	0.000	0.997	0.003
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.997	0.003
C77.9 Lymph node, unspecified	0.003	0.997	0.000
N36.3 Prolapsed urethral mucosa	0.003	0.997	0.000
S46.9 Injury of unspecified muscle and tendon at shoulder and upper arm level	0.000	0.997	0.002
Z13.9 Special screening examination, unspecified	0.003	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
R39.8 Other and unspecified symptoms and signs involving the urinary system	0.000	0.997	0.003
H51 Other disorders of binocular movement	0.002	0.997	0.000
M31 Other necrotising vasculopathies	0.000	0.997	0.003
M31.3 Wegener's granulomatosis	0.000	0.997	0.002
R49 Voice disturbances	0.000	0.997	0.002
H27.8 Other specified disorders of lens	0.000	0.998	0.002
Z50 Care involving use of rehabilitation procedures	0.000	0.998	0.002
M16.7 Other secondary coxarthrosis	0.002	0.998	0.000
M31.0 Hypersensitivity angiitis	0.000	0.998	0.002
S46.8 Injury of other muscles and tendons at shoulder and upper arm level	0.000	0.998	0.002
M16.5 Other posttraumatic coxarthrosis	0.002	0.998	0.000
S46.3 Injury of muscle and tendon of triceps	0.000	0.998	0.002
F52 Sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
C21 Malignant neoplasm of anus and anal canal	0.002	0.998	0.000
Z50.1 Other physical therapy	0.000	0.998	0.002
N36.1 Urethral diverticulum	0.002	0.998	0.000
L60.2 Onychogryphosis	0.002	0.998	0.000
H51.9 Disorder of binocular movement, unspecified	0.002	0.998	0.000
M16.4 Posttraumatic coxarthrosis, bilateral	0.002	0.998	0.000
M31.4 Aortic arch syndrome [Takayasu]	0.000	0.998	0.002
E11.5 With peripheral circulatory complications	0.000	0.998	0.002
K65-K67 Diseases of peritoneum	0.000	0.998	0.002
F40.2 Specific (isolated) phobias	0.000	0.998	0.002
M31.8 Other specified necrotising vasculopathies	0.000	0.998	0.002
H54.9 Unspecified visual impairment (binocular)	0.000	0.998	0.002
Z50.8 Care involving use of rehabilitation procedures	0.000	0.998	0.002
E88.8 Other specified metabolic disorders	0.000	0.998	0.002
H51.8 Other specified disorders of binocular movement	0.002	0.998	0.000
H51.1 Convergence insufficiency and excess	0.002	0.998	0.000
H51.0 Palsy of conjugate gaze	0.002	0.998	0.000
M31.2 Lethal midline granuloma	0.000	0.998	0.002
H52.3 Anisometropia and aniseikonia	0.002	0.998	0.000
Q24.8 Other specified congenital malformations of heart	0.000	0.998	0.002
R49.2 Hypernasality and hyponasality	0.000	0.998	0.002
Z50.6 Orthoptic training	0.000	0.998	0.002
F52.0 Lack or loss of sexual desire	0.002	0.998	0.000
S61.8 Open wound of other parts of wrist and hand	0.002	0.998	0.000
M16.6 Other secondary coxarthrosis, bilateral	0.002	0.998	0.000
M31.1 Thrombotic microangiopathy	0.000	0.998	0.002
L60 Nail disorders	0.002	0.998	0.000
M24.07 Loose body in joint (Ankle and foot)	0.002	0.998	0.000
K65.0 Acute peritonitis	0.000	0.998	0.002
N36.0 Urethral fistula	0.002	0.998	0.000
C21.2 Cloacogenic zone	0.002	0.998	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
F52.7 Excessive sexual drive	0.002	0.998	0.000
F52.6 Nonorganic dyspareunia	0.002	0.998	0.000
F52.5 Nonorganic vaginismus	0.002	0.998	0.000
F52.4 Premature ejaculation	0.002	0.998	0.000
F52.3 Orgasmic dysfunction	0.002	0.998	0.000
F52.1 Sexual aversion and lack of sexual enjoyment	0.002	0.998	0.000
M16.2 Coxarthrosis resulting from dysplasia, bilateral	0.002	0.998	0.000
M31.7 Microscopic polyangiitis	0.000	0.998	0.002
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.000	0.998	0.002
Q18.0 Sinus, fistula and cyst of branchial cleft	0.002	0.998	0.000
Q21.1 Atrial septal defect	0.002	0.998	0.000
R49.8 Other and unspecified voice disturbances	0.000	0.998	0.002
C21.8 Overlapping lesion of rectum, anus and anal canal	0.002	0.998	0.000
H51.2 Internuclear ophthalmoplegia	0.002	0.998	0.000
N36 Other disorders of urethra	0.002	0.998	0.000
G62.8 Other specified polyneuropathies	0.002	0.998	0.000
I24.1 Dressler's syndrome	0.002	0.998	0.000
M31.9 Necrotising vasculopathy, unspecified	0.000	0.998	0.002
Z50.3 Drug rehabilitation	0.000	0.998	0.002
S61.7 Multiple open wounds of wrist and hand	0.002	0.998	0.000
J93 Pneumothorax	0.000	0.998	0.002
Z50.2 Alcohol rehabilitation	0.000	0.998	0.002
K67 Disorders of peritoneum in infectious diseases classified elsewhere	0.000	0.998	0.002
H27.0 Aphakia	0.000	0.998	0.002
J38.3 Other diseases of vocal cords	0.000	0.998	0.002
X68.9 Unspecified place	0.000	0.998	0.002
Z80.5 Family history of malignant neoplasm of urinary tract	0.000	0.998	0.002
R59.1 Generalised enlarged lymph nodes	0.002	0.998	0.000
S60 Superficial injury of wrist and hand	0.002	0.998	0.000
M23.03 Cystic meniscus (Medial collateral ligament or Other and unspecified medial meniscus)	0.000	0.998	0.002
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
K76 Other diseases of liver	0.000	0.998	0.002
R44.1 Visual hallucinations	0.000	0.998	0.002
H27 Other disorders of lens	0.000	0.998	0.002
F20.9 Schizophrenia, unspecified	0.000	0.998	0.002
E88.9 Metabolic disorder, unspecified	0.000	0.998	0.002
G41.9 Status epilepticus, unspecified	0.000	0.998	0.002
L60.5 Yellow nail syndrome	0.002	0.998	0.000
L60.4 Beau's lines	0.002	0.998	0.000
L60.0 Ingrowing nail	0.002	0.998	0.000
I24 Other acute ischaemic heart diseases	0.002	0.998	0.000
S32.40 Fracture of acetabulum (closed)	0.000	0.998	0.002
L60.3 Nail dystrophy	0.002	0.998	0.000
M31.5 Giant cell arteritis with polymyalgia rheumatica	0.000	0.998	0.001
S60.1 Contusion of finger(s) with damage to nail	0.002	0.998	0.000
J93.0 Spontaneous tension pneumothorax	0.000	0.998	0.002
N36.8 Other specified disorders of urethra	0.002	0.998	0.000
N48.4 Impotence of organic origin	0.002	0.998	0.000
S32.0 Fracture of lumbar vertebra	0.000	0.998	0.002
D72.1 Eosinophilia	0.000	0.998	0.002
H27.1 Dislocation of lens	0.000	0.998	0.002
J39.2 Other diseases of pharynx	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations